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A B S T R A C T
Background
Pneumonia occurring in residents of long-term care facilities and nursing homes can be termed ’nursing home-acquired pneumonia’
(NHAP). NHAP is the leading cause of mortality among residents. NHAP may be caused by aspiration of oropharyngeal flora into
the lung, and by failure of the individual’s defence mechanisms to eliminate the aspirated bacteria. Oral care measures to remove or
disrupt oral plaque might be effective in reducing the risk of NHAP.
Objectives
To assess effects of oral care measures for preventing nursing home-acquired pneumonia in residents of nursing homes and other long-
term care facilities.
Search methods
CochraneOralHealth’s Information Specialist searched the following databases: CochraneOralHealth’s Trials Register (to 15November
2017), the Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library, 2017, Issue 10), MEDLINE Ovid
(1946 to 15 November 2017), and Embase Ovid (1980 to 15 November 2017) and Cumulative Index to Nursing and Allied Health
Literature (CINAHL; 1937 to 15 November 2017). The US National Institutes of Health Trials Registry (ClinicalTrials.gov) and the
World Health Organization International Clinical Trials Registry Platform were searched for ongoing trials. No restrictions were placed
on the language or date of publication when searching the electronic databases. We also searched the Chinese Biomedical Literature
Database, the China National Knowledge Infrastructure, and the Sciencepaper Online to 20 November 2017.
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Selection criteria
We included randomised controlled trials (RCTs) that evaluated the effects of oral care measures (brushing, swabbing, denture cleaning
mouthrinse, or combination) in residents of any age in nursing homes and other long-term care facilities.
Data collection and analysis
At least two review authors independently assessed search results, extracted data, and assessed risk of bias in the included studies. We
contacted study authors for additional information. We pooled data from studies with similar interventions and outcomes. We reported
risk ratio (RR) for dichotomous outcomes, mean difference (MD) for continuous outcomes, and hazard ratio (HR) for time-to-event
outcomes, using random-effects models.
Main results
We included four RCTs (3905 participants), all of which were at high risk of bias. The studies all evaluated one comparison: professional
oral care versus usual oral care. We did not pool the results from one study (N = 834 participants), which was stopped at interim analysis
due to lack of a clear difference between groups.
We were unable to determine whether professional oral care resulted in a lower incidence rate of NHAP compared with usual oral care
over an 18-month period (hazard ratio 0.65, 95% CI 0.29 to 1.46; one study, 2513 participants analysed; low-quality evidence).
We were also unable to determine whether professional oral care resulted in a lower number of first episodes of pneumonia compared
with usual care over a 24-month period (RR 0.61, 95% CI 0.37 to 1.01; one study, 366 participants analysed; low-quality evidence).
There was low-quality evidence from two studies that professional oral care may reduce the risk of pneumonia-associated mortality
compared with usual oral care at 24-month follow-up (RR 0.41, 95% CI 0.24 to 0.72, 507 participants analysed).
We were uncertain whether or not professional oral care may reduce all-cause mortality compared to usual care, when measured at 24-
month follow-up (RR 0.55, 95% CI 0.27 to 1.15; one study, 141 participants analysed; very low-quality evidence).
Only one study (834 participants randomised) measured adverse effects of the interventions. The study identified no serious events
and 64 non-serious events, the most common of which were oral cavity disturbances (not defined) and dental staining.
No studies evaluated oral care versus no oral care.
Authors’ conclusions
Although low-quality evidence suggests that professional oral care could reduce mortality due to pneumonia in nursing home residents
when compared to usual care, this finding must be considered with caution. Evidence for other outcomes is inconclusive. We found
no high-quality evidence to determine which oral care measures are most effective for reducing nursing home-acquired pneumonia.
Further trials are needed to draw reliable conclusions.
P L A I N L A N G U A G E S U M M A R Y
Mouth care for preventing pneumonia in nursing homes
Review question
Does oral (mouth) care cut down pneumonia (a lung infection) in nursing homes? We aimed to summarise the findings from studies
known as ’randomised controlled trials’ in order to identify whether mouth care helped prevent pneumonia in elderly people living in
nursing homes or other care facilities, and which approach to mouth care was best.
Background
Pneumonia is common among elderly people living in nursing homes. Nursing home-acquired pneumonia (NHAP) is a bacterial
infection of the lung that occurs in residents of long-term care facilities and nursing homes. Poor oral hygiene is considered to contribute
to the likelihood of contracting an infection. Professional mouth care is a combination of brushing teeth and mucosa, cleaning dentures,
using mouthrinse, and check-up visits to a dentist, while usual mouth care is generally less intensive, and is self-administered, or
provided by nursing home staff without special training in oral hygiene.
Study characteristics
2Oral care measures for preventing nursing home-acquired pneumonia (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
This review was carried out through Cochrane Oral Health. We searched scientific databases for relevant studies, up to 15 November
2017. We included four studies, with a total of 3905 participants randomly assigned to treatment or usual care. Participants were long-
term-care elderly residents in nursing homes who did not have pneumonia at the beginning of the studies. Some of the participants
had dementia or systemic diseases. All studies focused on the comparison between ’professional’ mouth care and ’usual’ mouth care.
None of the studies evaluated oral care versus no oral care.
Key results
We identified four studies, all of which compared professional mouth care to usual mouth care in nursing home residents.
From the limited evidence, we could not tell whether professional oral mouth care was better or worse than usual mouth care for
preventing pneumonia. The evidence for death from any cause was inconclusive, but the studies did suggest that professional mouth
care may reduce the number of deaths caused by pneumonia, compared to usual mouth care, when measured after 24 months.
Only one study measured negative effects of the interventions, and reported that there were no serious events. The most common non-
serious events reported were damage to the mouth and tooth staining.
Quality of the evidence
The quality of the evidence is low or very low, because of the small number of studies and problems with their design. Therefore, we
cannot rely on the findings, and further research is required.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Professional oral care versus usual oral care
Population: elderly people
Setting: nursing homes
Intervention: professional oral care
Comparison: usual oral care
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
Number of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Usual oral care Professional oral care
Incidence rate of NHAP
Clinical and radiologi-
cal assessment
Follow-up: 18 months
5.1 per 10,000
pat ient-days
3.3 per 10,000
(2.7 to 4.1) pat ient-days
HR 0.65
(0.29 to 1.46)
2513
(1 study)
⊕⊕©©
low a,b
A second study (834
part icipants) that was
stopped at interim anal-
ysis, with an average
1.13-year follow-up, re-
ported that the HR of
incidence rate of NHAP
was 1.12 (0.84 to 1.50)
Incidence proportion
(cumulative incidence)
of NHAP
Clinical and radiologi-
cal assessment
Follow-up: 24 months
187 per 1000 114 per 1000
(69 to 189)
RR 0.61
(0.37 to 1.01)
366
(1 study)
⊕⊕©©
low a,b
A second study (2513
part icipants) reported
that the RR of cumula-
t ive incidence of NHAP
at 18-month follow-up
was 0.87, 95% CI 0.69
to 1.09
Mortality (pneumonia-
associated)
Clinical and radiologi-
cal assessment
Follow-up: 24 months
154 per 1000 63 per 1000
(37 to 111)
RR 0.41
(0.24 to 0.72)
507
(2 studies)
⊕⊕©©
low c
A third study (2513 par-
t icipants) reported that
the RR of pneumo-
nia-associated mortal-
ity at 18-month follow-
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up was 1.09, 95% CI 0.
58 to 2.05
Mortality (all- cause)
Clinical assessment
Follow-up: 24 months
234 per 1000 129 per 1000
(63 to 270)
RR 0.55
(0.27 to 1.15)
141
(1 study)
⊕©©©
very low b,c
A second study (834
part icipants) that was
stopped at interim anal-
ysis, with an average
follow-up of 1.13 years,
reported that the HR of
all-cause mortality was
1.16, 95% CI 0.88 to 1.
53
Adverse effects of in-
terventions
Measured in one study only, which reported that there were no serious events and 64 non-serious events, the most common of which were oral cavity
disturbances (not def ined) and dental staining
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; RR: risk rat io; HR: hazard rat io
NHAP: nursing home-acquired pneumonia
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
a Downgraded one level due to serious risk of bias (performance bias)
b Downgraded one level due to serious imprecision
c Downgraded two levels due to serious risk of bias (performance bias and attrit ion bias)
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B A C K G R O U N D
Description of the condition
Residents of nursing homes and long-term care facilities are com-
prised predominantly of a geriatric population. Institutionalised
older adults are prone to poor oral health because they have re-
duced access to professional dental care, and are unable tomaintain
the practice of good personal oral hygiene (Berg 2000; Gaszynska
2014). Many studies have found that older adults require profes-
sional oral hygiene care as well as personal oral hygiene instruction
(e.g. Frenkel 2000; Gaszynska 2014; Gluhak 2010; Petelin 2012).
The incidence of community-acquired pneumonia (CAP) requir-
ing hospitalisation is 1.96 to 10 times higher amongst elderly
nursing home residents than community-dwelling elderly people
(Marrie 2002; Ronald 2008; Ticinesi 2016), with a 2.29 times
higher rate of 30-day mortality (Liapikou 2014). This may be at-
tributable to the particular characteristics of residents of nursing
homes and long-term care facilities, as they tend to be older, have
greater functional impairment, and to have increased comorbidi-
ties, polypharmacy, anddependence upon caregivers (Dudas 2000;
Martínez-Moragón 2004). Pneumonia occurring in residents of
long-term care facilities and nursing homes can be termed nurs-
ing home-acquired pneumonia (NHAP); it closely resembles CAP,
and may be caused by multidrug-resistant bacteria (Craven 2006;
Mylotte 2002). This is suggested by data from the United States
and Asia (Micek 2007; Nakagawa 2014), but is not confirmed by
European data (Brito 2009; Ewig 2010). Nursing home-acquired
pneumonia is the leading cause of mortality among residents (Cho
2011; Nicolle 1996). Its reportedmean incidence ranges from 1 to
3.2 per 1000 patient days, with 600,000 emergency department
admissions (El-Solh 2010; Medina-Walpole 1999; Muder 1998).
It has been suggested that NHAP may be caused by aspiration of
oropharyngeal flora into the lung, and by failure of host defence
mechanisms to eliminate aspirated bacteria (Scannapieco 2014;
Verghese 1983).
Comorbidities considered to be risk factors for NHAP include the
following (Klapdor 2012; Ticinesi 2016):
• physical impairment;
• dementia;
• chronic obstructive pulmonary disease;
• mechanical ventilation;
• ageing.
A growing body of evidence shows that poor oral hygiene and oral
hygiene-related factors (e.g. denture use (O’Donnell 2016), being
edentulous (Abe 2008)) may be additional risk factors for aspira-
tion pneumonia among the elderly, who have an increased rate of
dental plaque colonisation as a possible reservoir for pathogenic
organisms associated with CAP or NHAP (Bassim 2008; Janssens
2005; Scannapieco 2003). A systematic review by Azarpazhooh
2006 concluded that there was fair evidence (II-2, grade B recom-
mendation) of an association between pneumonia and oral health,
and good evidence (I, grade A recommendation) that better oral
health and frequent professional oral care reduced the occurrence
or progression of respiratory disease among high-risk elderly liv-
ing in nursing homes, and especially those in intensive care units.
However, anRCTby Juthani-Mehta 2015 indicated that advanced
oral care measures did not significantly reduce the incidence of
radiographically-confirmed pneumonia or lower respiratory tract
infection compared with usual care, in residents of nursing homes.
Given that NHAP may be linked to oral hygiene, interventions
for maintaining good oral hygiene might be of significant interest
for this population.
Description of the intervention
It is widely believed that improved oral hygiene and frequent
professional oral health care can be effective in reducing the in-
cidence or progression of respiratory infection in residents of
nursing homes and long-term care facilities (Azarpazhooh 2006;
Scannapieco 2003; Sjögren 2008; Watando 2004). Multiple oral
care measures have been reinforced by the National Institute for
Health and Care Excellence (NICE) guideline that introduced de-
tailed oral care measures, and recommended that care home man-
agers should ensure care home policies set out plans and actions
to promote and protect residents’ oral health (NICE guideline
2016). The nature of oral care measures that have been proposed
is diverse, but they can be classified broadly as follows.
• Mechanical aids to remove plaque and debris from the oral
cavity, for example:
◦ toothbrushing;
◦ swabbing with water.
• Topical (chemical) disinfection to reduce colonisation, for
example:
◦ mouthrinse;
◦ sprays;
◦ liquids;
◦ gels.
Antiseptics are broadly defined to include saline, chlorhexidine,
povidone-iodine, cetylpyridium, and others, but to exclude an-
tibiotics (Shi 2013).
• Combination of mechanical plaque removal and topical
disinfection, for example:
◦ swabbing with antiseptic;
◦ toothbrushing with antibacterial toothpaste;
◦ daily toothbrushing plus antiseptic rinse.
• Professional dental care, for example:
◦ aided toothbrushing;
◦ suction to remove excess fluid.
Oral care measures can be delivered at any frequency, by care-
givers, nurses, dental care professionals, or dentists (Ekstrand
2013; Zuluaga 2012).
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How the intervention might work
Increasing evidence suggests a link between colonisation of bac-
teria and respiratory infection and pneumonia. Gram-negative
bacilli, such as Pseudomonas aeruginosa,Klebsiella pneumoniae, and
Enterobacter species, have been suspected as causative pathogens
of pneumonia (Craven 1992; Liapikou 2014). Dependent and
frail elderly patients have a higher detection rate of gram-negative
bacilli in their oropharyngeal cavities (Leibovitz 2003; Mylotte
1994; Palmer 2001). Sumi 2007 showed that in a group of 138
dependent elderly, a potential respiratory pathogen colonised the
dental plaques of 89 participants (64.5%). Aspiration of oropha-
ryngeal fluid may cause translocation and colonisation of po-
tential pulmonary pathogens in the lower respiratory tract and
lungs (Gibbons 1989; Munro 2004; Whittaker 1996); the latter
may cause aspiration pneumonia (Van derMaarel-Wierink 2013).
Therefore, oral care measures that reduce the colonisation of bac-
teria could result in decreased risk of pneumonia.
The risk of NHAP might be reduced by measures that mechani-
cally disrupt the biofilm (such as manual or electric toothbrush-
ing), by the use of oral antiseptics that may remain active on oral
tissues for several hours after application, or both, thus reduc-
ing the build-up of plaque. For example, chlorhexidine (CHX)
gluconate is a broad-spectrum antiseptic agent that reduces both
gram-positive and gram-negative bacteria associated with respira-
tory tract infection; it can remain chemically active on tissue for up
to six hours (Tantipong 2008). Oral conditions of elderly people
have been shown to be improved by rinsing with 0.12% CHX so-
lution daily or weekly for six weeks (DeRiso 1996; Persseon 1991).
Similarly, manual oral brushing improves oral hygiene by reduc-
ing bacterial pathogen colonisation, and improves the swallowing
reflex by stimulating gums (Yamaya 2001; Yoshino 2001). With
removal or disruption of the oral plaque, pneumonia could be
significantly reduced (Shi 2013; Van der Maarel-Wierink 2013).
Such oral care measures can be used alone, or in combination.
For example, Yoshida 2001 found that brushing teeth after each
meal and rinsing daily with 1% povidone-iodine, in conjunction
with weekly professional dental care, significantly decreased the
incidence of pneumonia in nursing homes.
Why it is important to do this review
Cochrane Oral Health undertook an extensive prioritisation exer-
cise in 2014 to identify a core portfolio of clinically important re-
view titles to bemaintained inThe Cochrane Library (Worthington
2015). The dental public health expert panel identified this review
as a priority title (ohg.cochrane.org/priority-reviews).
Although good oral hygiene has been shown to play an impor-
tant role in maintaining the oral health and well-being of institu-
tionalised people, oral care measures have generally been afforded
low priority in nursing homes. In some guidelines, such as British
Thoracic Society guidance on the prevention of CAP, oral hy-
giene is not mentioned (Lim 2009).Moreover, nurses have limited
knowledge about providing mouth care in general (Frenkel 2000;
Jablonski 2005; Pyle 2005). Chiba 2009 reported that 32.4% of
caregivers hesitated to provide oral care measures, which indicated
their lack of knowledge about oral hygiene, but bespoke oral health
education has been shown to have a positive effect on caregivers’
knowledge and attitudes (Charteris 2001; Frenkel 2001; Frenkel
2002; Sjögren 2010). A systematic review by Kaneoka 2015 found
that mechanical oral cleaning significantly reduced the risk of fa-
tal pneumonia in residents in nursing homes. However, no other
kinds of oral care measures were evaluated, and no Cochrane sys-
tematic review has focused on this issue.
We believe it is important to synthesise the evidence from ran-
domised controlled trials of oral care interventions that have eval-
uated their effectiveness in reducing NHAP. Identifying effective
oral care interventions is also an essential step towards improving
oral health and quality of life for nursing home residents.
O B J E C T I V E S
To assess the effects of oral care measures for preventing nurs-
ing home-acquired pneumonia in residents of nursing homes and
other long-term care facilities.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included parallel randomised controlled trials (RCTs) assessing
the effects of oral care measures in residents of nursing homes
and other long-term care facilities. We included cluster-RCTs, for
which the unit of randomisation was the care facility. We excluded
cross-over trials.
Wu 2009 showed that trials carried out in China often used the
terminology of randomisation in a broader way than was usual
in other countries, such as the UK. Therefore, we contacted the
authors of studies written in Chinese to request a description of
the randomisation method used, and included only those trials
where participants’ allocation to treatment was random.
We included all studies of oral care in which the purpose of the
study was to reduce the incidence of pneumonia. We excluded
studies that reported only intermediate outcomes, such as dental
plaque and gingivitis, without providing data on pneumonia.
We did not include studies for which the only available informa-
tion was presented in an abstract, with no record of a full-text pub-
lication; since this would have provided insufficient information
for a full assessment of risk of bias.
7Oral care measures for preventing nursing home-acquired pneumonia (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Types of participants
Residents of any age in nursing homes and other long-term care fa-
cilities (e.g. rehabilitation units, medical care facilities), regardless
of oral health status (e.g. edentulous or dentate, using dentures,
having physical or intellectual disabilities, beingmechanically ven-
tilated, using alternative feeding route). We excluded participants
with pneumonia or respiratory infection at baseline.
Types of interventions
We included studies comparing oral caremeasure(s) for prevention
of NHAP versus no treatment, placebo, usual care, or any other
oral care measure(s) used to prevent NHAP (head-to-head trials).
• Intervention group: participants received clearly defined
oral care measure(s), such as professional oral care (dentists,
dental hygienists, nurse-assisted tooth brushing), oral rinse, or
swab and topical decontamination with antiseptics, regardless of
frequency, dosage, or formulation.
• Control group: participants received placebo or another
specific oral care measure(s), no treatment, or usual care,
including self-care.
We excluded studies in which topical antibiotics were used only
in the intervention group.
Types of outcome measures
Primary outcomes
• Incidence, incidence proportion or prevalence of NHAP of
any severity (diagnosis of NHAP should have been based on
radiological results, clinical signs and symptoms, bacterial
culture, or some synthetic criteria (American Thoracic Society
2005))
• Mortality (pneumonia-associated)
• Mortality (all-cause)
Secondary outcomes
• Change in systemic antibiotic use: this parameter included
both the number of participants who had used systemic
antibiotics, and the duration of antibiotic use
• Adverse reactions to the interventions (both local and
systemic): this parameter referred to both the number of
participants who had adverse reactions, and the number of
adverse reactions
• Incidence or prevalence of fever: this included the
proportion of participants with fever higher than 37.8°C, and
prolonged number of febrile days
• Change in data on economics and quality of life
• Oral health indices, such as gingival index, plaque index,
bleeding index, periodontal index, etc.
Search methods for identification of studies
Electronic searches
Cochrane Oral Health’s Information Specialist conducted system-
atic searches in the following databases for randomised controlled
trials and controlled clinical trials. There were no language, pub-
lication year or publication status restrictions:
• Cochrane Oral Health’s Trials Register (searched 15
November 2017; see Appendix 1);
• Cochrane Central Register of Controlled Trials
(CENTRAL; in the Cochrane Register of Studies, searched 15
November 2017; see Appendix 2);
• MEDLINE Ovid (1946 to 15 November 2017; see
Appendix 3);
• Embase Ovid (1980 to 15 November 2017; see Appendix
4);
• CINAHL EBSCO (Cumulative Index to Nursing and
Allied Health Literature; 1937 to 15 November 2017; see
Appendix 5).
Subject strategiesweremodelled on the search strategy designed for
MEDLINE Ovid. Where appropriate, they were combined with
subject strategy adaptations of the highly sensitive search strategy,
designed by Cochrane for identifying randomised controlled trials
and controlled clinical trials, as described in the Cochrane Hand-
book for Systematic Reviews of Interventions Chapter 6 (Lefebvre
2011).
We also searched:
• Chinese Biomedical Literature Database (1978 to 20
November 2017; see Appendix 6);
• China National Infrastructure (1994 to 20 November
2017; see Appendix 7).
Searching other resources
Cochrane Oral Health’s Information Specialist searched the fol-
lowing databases for ongoing trials:
• US National Institutes of Health Ongoing Trials Register
ClinicalTrials.gov ( clinicaltrials.gov/; searched 15 November
2017; see Appendix 8);
• World Health Organization International Clinical Trials
Registry Platform ( apps.who.int/trialsearch; searched 15
November 2017; see Appendix 9).
We also searched Sciencepaper Online (searched 20 November
2017; see Appendix 10).
We searched the reference lists of included studies and identified
review articles for additional papers.
We did not perform a separate search for adverse effects of in-
terventions. We considered adverse effects described in included
studies only.
Review authors scanned records from 19 Chinese dental and nurs-
ing journals (2000 to 2010), as listed below.
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• Chinese Journal of Stomatology,
• Journal of Practical Stomatology,
• Shanghai Journal of Stomatology,
• Journal of Clinical Stomatology,
• West China Journal of Stomatology,
• Journal of Modern Stomatology,
• Journal of Stomatology,
• Journal of Oral Science Research,
• Journal of Dental Prevention and Treatment,
• International Journal of Stomatology,
• Beijing Journal of Stomatology,
• Chinese Journal of Geriatric Dentistry,
• Chinese Journal of Nursing,
• Chinese Nursing Management,
• Nursing Journal of Chinese People’s Liberation,
• Journal of Nursing Science,
• Chinese Journal of Practical Nursing,
• Chinese Nursing Research,
• Modern Clinical Nursing.
Data collection and analysis
Selection of studies
Two review authors independently screened the titles and abstracts
of the reports retrieved by the searches. The search was designed to
be sensitive, and include controlled clinical trials. These were fil-
tered out early in the selection process if theywere not randomised.
We independently assessed eligibility according to the inclusion
criteria, and obtained full-text copies of studies that appeared to
meet the inclusion criteria, or when information in the title or the
abstract was insufficient to allow us to make a clear judgement
of eligibility. We resolved disagreements by discussion within the
review author team.
From the retrieved full-text articles, we discarded studies that
clearly did not meet the inclusion criteria, and recorded the rea-
sons for exclusion in the ’Characteristics of excluded studies’ table.
Data extraction and management
Two review authors independently extracted data, and resolved
disagreements by discussion.
We created a data extraction form and piloted it on three of
the included studies. Two review authors independently extracted
the following data, and recorded them in the ’Characteristics of
included studies’ tables.
• Trial design, with inclusion and exclusion criteria, duration,
setting, and location of the study.
• Demographic data of participants and risk factors for
NHAP, including proportions of non-oral feeding, dysphagia,
xerostomia, tongue coating, mechanical ventilation, and
methicillin-resistant Staphylococcus aureus (MRSA).
• Diagnostic criteria of CAP or NHAP: outcomes, such as
incidence of NHAP and mortality; oral, dental, and respiratory
health status before and after treatment; any adverse reactions
potentially relevant to the interventions; and timing of
measurement.
• Management and intensity of specific interventions.
If any important data were missing, we contacted the authors of
the study to request them.We collected data frommultiple reports
of single trials, and analysed them as from a single trial.
Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias, and re-
solved disagreements by discussion. We used the Cochrane tool
for assessing risk of bias (Higgins 2011a).
We used seven items to assess the risk of bias in included studies.
For each item, we provided information from the trial report on
measures taken to address possible bias, and arrived at a judgement
of ’low risk’, ’unclear risk’ and ’high risk’ of bias. We presented the
seven domains and their descriptions below.
• Random sequence generation: selection bias (biased
allocation to interventions) due to inadequate generation of a
randomised sequence. We considered low risk of bias only if the
generation of random numbers was clearly described. We
considered an unclear description of random sequence
generation with the phase ’stratified randomisation’, ’block
randomisation scheme’, or ’randomisation completed by
statistician or nurse’ as having unclear risk of bias.
• Allocation concealment: selection bias (biased allocation to
interventions) due to inadequate concealment of the allocation.
• Blinding of participants and personnel: performance bias
due to knowledge of the allocated interventions by participants
and personnel during the trial. We judged trials with completely
different treatment arms that would be impossible to blind as
having high risk of performance bias, even if details of blinding
were not reported.
• Blinding of outcome assessment: detection bias due to
knowledge of allocated interventions by outcome assessors.
• Incomplete outcome data: attrition bias due to quantity,
nature, or handling of incomplete outcome data.
• Selective reporting: reporting bias due to selective outcome
reporting.
• Other bias: bias due to problems not covered elsewhere in
the table, such as baseline imbalance, contamination, or co-
intervention.
We classified the overall risk of bias in included studies as below.
We summarised the risk of bias information graphically.
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Risk of bias Interpretation In outcome In included studies
Low risk of bias Plausible bias unlikely to seriously
alter the results
Low risk of bias for all key domains Most information was from studies
at low risk of bias.
Unclear risk of bias Plausible bias that raised some
doubt about the results
Unclear risk of bias for one or more
key domains
Most information was from studies
at low or unclear risk of bias
High risk of bias Plausible bias that seriously weak-
ened confidence in the results
High risk of bias for one or more
key domains
The proportion of information
from studies at high risk of bias was
sufficient to affect interpretation of
results
Measures of treatment effect
We treated the incidence proportion and prevalence of NHAP
as dichotomous data (presence or absence) and the incidence of
NHAP and mortality as time-to-event data when these were re-
ported.
For dichotomous outcomes, we calculated the effect estimate as a
risk ratio (RR) with 95% confidence interval (CI).
For time-to-event data, we expressed the treatment effect as a haz-
ard ratio (HR) or a rate ratio. If the HR was not reported, we
calculated the log HR and the standard error from available sum-
mary statistics or Kaplan-Meier curves, according to the methods
proposed by Parmar 1998, or we requested the data from study
authors.
For continuous outcomes, when studies used the same scale, we
used mean values and standard deviations (SDs) to express the
estimate of effect as amean difference (MD), with 95%confidence
interval (CI).When different scales were used tomeasure the same
outcome, we used the standardised mean difference (SMD), with
95% CI, as the effect measure.
We anticipated that the number of participants reporting adverse
reactions would be low, so we calculated a Peto odds ratio as the
effect estimate.
Unit of analysis issues
We used the individual as the unit of analysis in this review, and
we analysed only participant-level data. For cluster-RCTs analysed
and reported by statistical measures that took clustering into ac-
count, we used the reported effect estimate and the standard error.
When the investigators did not take clustering into consideration
in their analyses, we attempted to re-analyse trial data using ap-
proximate analyses with an ’effective sample size’. We calculated
and used external estimates of the intracluster correlation coeffi-
cient (ICC) from similar trials (when available) to calculate the
design effect (Deeks 2011).
Dealing with missing data
We contacted the first and corresponding authors of the trial to
request missing details and summary statistics. Where no response
was received, we used standard methods provided in the Cochrane
Handbook for Systematic Reviews of Interventions to extract approx-
imate summary statistics (Higgins 2011b).
Assessment of heterogeneity
For each meta-analysis, we assessed clinical heterogeneity by ex-
amining characteristics of studies and similarities between types
of participants, interventions, and outcomes. We used Cochran’s
Q test to determine the presence of statistical heterogeneity at a
significance level of 0.1. We used the I² statistic (plus 95% confi-
dence interval) to quantify the degree of statistical heterogeneity
as follow (Deeks 2011).
• 0% to 40% may indicate slight heterogeneity.
• 30% to 60% may indicate moderate heterogeneity.
• 50% to 90% may indicate substantial heterogeneity.
• 75% to 100% may indicate very substantial heterogeneity.
If substantial or very substantial heterogeneity existed,we provided
a narrative description of the results instead of pooling data.
Assessment of reporting biases
To assess whether results were influenced by publication bias, we
had planned to construct a funnel plot to assess asymmetry (as-
suming we had at least 10 trials). We had planned to use tests for
funnel plot asymmetry, such as Egger’s methods for continuous
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data (Egger 1997), andBegg’smethods for dichotomous and time-
to-event data (Begg 1994).
Data synthesis
We undertook meta-analysis only when studies of similar compar-
isons reported the same outcomes. Our general approach to data
synthesis was to use a random-effects model. With this approach,
the CI for the pooled average intervention effect was wider than
the value that would be obtained if a fixed effect approach was
used, leading to a more conservative interpretation.
Subgroup analysis and investigation of heterogeneity
Had there been sufficient studies and heterogeneity, we would
have considered subgroup analyses: types of oral care measures,
trial design (cluster or parallel), length of follow-up, characteristics
of participants (dentate or edentulous, with or without physical
or intellectual disabilities), characteristics of oral care measures
(e.g. concentrations of the solutions used, mechanical or topical
intervention), and diagnostic criteria of the outcome (clinical or
radiological).
Sensitivity analysis
To test the stability of the judgements we made during the review
process, if necessary, wewould have undertaken sensitivity analyses
that included only trials at low risk of bias or only trials using
intention-to-treat (ITT) analysis.
If any meta-analyses had included several small trials and a sin-
gle very large trial, we would have undertaken a sensitivity analy-
sis comparing the effect estimates from both random-effects and
fixed-effectmodels. If these were different, wewould have reported
on both analyses as part of the results section, and we would have
considered possible interpretation.
Assessing the quality of the evidence
We had planned to assess the quality of the body of evidence for
comparisons of clinical importance. At least two of the review
authors, with no conflicts of interest, used GRADE criteria and
GRADE profiler software to independently judge the quality of
the evidence for our only comparison (Atkins 2004; Guyatt 2008;
Schünemann 2011). Evidence fromRCTs is regarded as high qual-
ity, and our confidence in the body of evidence might be decreased
due to study limitations (risk of bias), indirectness of the evidence,
heterogeneity, imprecision of effect estimates, and risk of publica-
tion bias (see above Assessment of reporting biases). We classified
the quality of a body of evidence into one of four categories: high,
moderate, low, or very low (Guyatt 2008).
Summarising findings
Wepresented all important comparisons and key outcomes (pneu-
monia, death, and adverse effects) in the ’Summary of findings’
tables, together with illustrative comparative risks, relative effect,
numbers of participants and studies involved, quality of the evi-
dence, and related comments. We used GRADEpro GDT to de-
velop the ’Summary of findings’ tables (GRADEpro GDT).
R E S U L T S
Description of studies
Results of the search
Through our electronic searches and handsearches, we identified
1849 references. There were 1173 records after we removed du-
plicates. After scanning the titles and abstracts, we considered 18
reports to be potentially eligible, and obtained the full texts for
further review.We included four studies (reported in eight articles)
in this systematic review, and two studies await classification. We
excluded the remaining eight records. The flow diagram is shown
in Figure 1.
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Figure 1. Study flow diagram
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Included studies
This review includes four randomised controlled trials (RCT),
which were published between 2002 and 2015 (Adachi 2002;
Bourigault 2011; Juthani-Mehta 2015; Yoneyama 2002). The de-
tails of the included studies are listed in the ’Characteristics of
included studies’ tables.
Trial designs and settings
All included studies used a two-arm parallel group design. Two
studies randomised individual participants, and two studies ran-
domised care homes, in a cluster-randomised design (Bourigault
2011; Juthani-Mehta 2015). The setting for all included studies
was a care home.
The durationof follow-up of participantswas 24months inAdachi
2002 and Yoneyama 2002, and 18 months in Bourigault 2011.
The duration of follow-up of participants was intended to be 30
months in the remaining trial, but the follow-up duration varied
among participants, with a mean follow-up of 1.13 years, when
the trial was terminated at the interim analysis for lack of clear
effect (Juthani-Mehta 2015).
Two studies were conducted in Japan (Adachi 2002; Yoneyama
2002), one in France (Bourigault 2011), and one in the United
States (Juthani-Mehta 2015).
Only one study reported sample size calculation (Juthani-Mehta
2015).
All four studies reported that they received non-industrial funding.
Participants
This review involved 3905 randomised participants. A total of 259
participants were lost during follow-up, leaving data from 3646
participants for analysis. Age and sex distribution of randomised
participants was not described in Bourigault 2011 or Yoneyama
2002. In the remaining two studies, the mean age was 86.0, and
the proportion of males was 24.1%. The inclusion criteria for par-
ticipants in the included studies generally specified long-term care
elderly residents of nursing homes, with no clinical pneumonia
at baseline. In Adachi 2002, several patients had febrile days at
the beginning of the trial, which did not exclude pneumonia, but
suggested susceptibility to pneumonia.
Interventions
We classified the identified interventions into two broad groups.
• Professional oral care: oral health care with instruction or
assistance of dental practitioners (dentists, dental hygienists,
dental nurses), or caregivers with professional oral health-related
knowledge, with interventions that consisted of more than basic
oral care (brushing teeth and denture everyday), with or without
oral disinfectants or mouth rinses
◦ Brushing teeth
◦ Brushing or swabbing buccal mucosa and tongue
◦ Cleaning denture(s)
◦ Mouthrinse
◦ Dental visit
• Usual oral care: basic oral health care (brushing teeth and
denture) without instruction or assistance of dental practitioners
(dentists, dental hygienists, dental nurses), or caregivers with
professional oral health-related knowledge, with or without the
use of oral disinfectants or mouthrinse
◦ Brushing teeth (varying frequency)
◦ May also include swabbing buccal mucosa and tongue
◦ May also include cleaning denture(s)
We evaluated the comparison between professional oral care and
usual oral care, which was further divided into two subgroups
according to the duration of follow-up:
• 18-month follow-up (Bourigault 2011);
• 24-month follow-up (Adachi 2002; Yoneyama 2002).
In Juthani-Mehta 2015, the participants were followed up for a
maximum of 2.5 years, but the follow-up duration was variable,
with a mean follow-up of 1.13 years at termination of the trial. As
such, we avoided including the number of events in any pooled
calculation.
No studies were identified comparing oral care versus no oral care.
Measures of primary outcomes
Incidence rate of nursing home-acquired pneumonia
(NHAP)
Incidence rate was defined as the number of new cases of pneu-
monia over the summed person-years/days of observation during
the trial follow-up. The incidence rate of NHAP was reported in
two studies (Bourigault 2011; Juthani-Mehta 2015).
Incidence proportion (cumulative incidence) of NHAP
We defined the incidence proportion as the proportion of the
initially disease-free population that developed pneumonia during
the trial follow-up. Incidence of NHAP was reported in three
studies (Bourigault 2011; Juthani-Mehta 2015; Yoneyama 2002).
Mortality (pneumonia-associated)
Three studies reported pneumonia-associated mortality during
follow-up (Adachi 2002; Bourigault 2011; Yoneyama 2002). This
outcome was reported as death due to aspiration pneumonia in
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Adachi 2002, pneumopathy in Bourigault 2011, and pneumonia
in Yoneyama 2002.
Mortality (all-cause)
Two studies reported the outcomes of all-cause death during fol-
low-up (Adachi 2002; Juthani-Mehta 2015). Adachi 2002 re-
ported both the number and the reasons of death; the reasons of
death were not reported in Juthani-Mehta 2015. Yoneyama 2002
stated that 51 participants died from causes other than pneumo-
nia, but did not present these data by group.
Measures of secondary outcomes
Change in systemic antibiotic use
No study reported this outcome.
Adverse reactions to the interventions
Adverse events were reported in only one study (Juthani-Mehta
2015). The adverse events reported in Juthani-Mehta 2015 were
mostly oral cavity disturbances and dental staining, but the authors
did not define oral cavity disturbances.
Incidence proportion or prevalence of fever
No study reported time-to-event data for incidence of fever. Two
studies reported fever as an outcome (Adachi 2002; Yoneyama
2002). In Adachi 2002, monthly proportions of participants with
fever, and the average prevalence of participants with fever were
described, but we could not extract the data for how many par-
ticipants had suffered from febrile days during 24-month follow-
up. In Yoneyama 2002, participants who had febrile days for more
than seven cumulative days during two years were assumed to
be participants with fever. Both studies considered a temperature
37.8°C or more as a feverish condition.
Change in data on economics and quality of life
No study reported change in economics as an outcome. Only one
study reported quality of life at several time points (Yoneyama
2002). They also assessed cognitive impairment and activities of
daily living (ADLs).
Oral health indices
Yoneyama 2002 reported the change of debris index (DI). No
other oral health indices were mentioned.
Studies awaiting classification
Two studies await classification (NCT00841074; Ohsawa 2003).
See Characteristics of studies awaiting classification.
Excluded studies
We excluded six studies, reported in eight publications, for the
reasons summarised below. See the ’Characteristics of excluded
studies’ table for details.
• Not an RCT: Bassim 2008 was a retrospective cohort study,
Hollaar 2017 used a non-randomised controlled design, and
Morino 2010 was a quasi-RCT.
• Did not assess pneumonia incidence or mortality: Izumi
2016; Quagliarello 2009; Watando 2004.
Risk of bias in included studies
See Figure 2; Figure 3.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study
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Allocation
Sequence generation
Juthani-Mehta 2015 adopted a permuted block randomisation
and Yoneyama 2002 used a random number table to achieve ran-
dom sequence generation, which we considered as low risk of bias.
The remaining two studies stated that allocation was random but
provided no further details, and were therefore assessed at unclear
risk of bias for this domain.
Allocation concealment
In three studies, allocation concealment was not described in suf-
ficient detail to determine risk of bias, and we rated these studies
at unclear risk of bias. We assessed Juthani-Mehta 2015 at low risk
of bias, because randomisation status of the home was revealed
after enrolment in the trial.
Blinding
In all four studies, blinding of the participants and their caregivers
to the allocated treatment was not possible because the active and
control treatments differed significantly. We assessed them at high
risk of performance bias.
Blinding of outcome assessment was possible in all of the included
studies, and was described in two studies, which we assessed as
being at low risk of detection bias (Juthani-Mehta 2015; Yoneyama
2002). In the other two studies, there was insufficient information
provided, and we judged the risk of detection bias to be unclear.
Incomplete outcome data
Juthani-Mehta 2015 applied intention-to-treat analysis, so we
judged it to be at low risk of attrition bias. We judged two other
studies as unclear risk of bias: Yoneyama 2002 excluded 12.2% of
participants due to fatal causes other than pneumonia from the
analysis; in Bourigault 2011, there was insufficient information
available to determine the risk of attrition bias. Adachi 2002 in-
cluded only some of the participants who had pneumonia-related
outcomes, and we judged it at high risk of attrition bias.
Selective reporting
All four included studies reported the outcomes specified in their
methods section in full, and we assessed them at low risk of re-
porting bias.
Other potential sources of bias
We assessed all four included studies at low risk of other bias.
Overall risk of bias
All four included studies were at high risk of bias overall.
Effects of interventions
See: Summary of findings for themain comparison Professional
oral care versus usual oral care; Summary of findings 2Oral care
versus no oral care
The four included studies evaluated professional versus usual oral
care (see Summary of findings for the main comparison).
Professional oral care versus usual oral care
Incidence rate of nursing home-acquired pneumonia
(NHAP)
Two studies reported the incidence of NHAP (Bourigault 2011;
Juthani-Mehta 2015). As Juthani-Mehta 2015 was stopped early,
we considered it inappropriate to pool the data from this trial.
In the Bourigault 2011 trial, they presented a crude incidence rate
of the first pneumonia episode of 3.3 (95% confidence interval
(CI) 2.7 to 4.1) per 10,000 days in the experimental group and 5.1
(95% CI 4.5 to 5.9) in the control group. There was no evidence
of a clear difference between professional oral care and usual oral
care on the incidence of NHAP at 18 months (hazard ratio (HR)
0.65, 95% CI 0.29 to 1.46; one study, 2513 participants analysed;
low-quality evidence; Analysis 1.1). In Juthani-Mehta 2015, the
authors reported a HR of 1.12 (95% CI 0.84 to 1.50; 834 partic-
ipants analysed) at the time that the study was stopped. Results in
both studies were compatible with an increase or a decrease or no
difference in the outcome as a result of professional oral care.
Incidence proportion (cumulative incidence) of NHAP
Three studies reported the incidence proportion of NHAP
( Bourigault 2011; Juthani-Mehta 2015; Yoneyama 2002) (
Analysis 1.2). In Bourigault 2011, the authors reported the prob-
ability of a first episode of pneumonia occurring at 18 months
from the time-to-event analysis, which was lower in the profes-
sional care group (15.2%, 95% CI 12.5 to 18.3) compared to the
usual care group (22.6%, 95% CI 19.7 to 25.8). Results were re-
ported as percentages only, the number of events and numbers of
participants on which this analysis was based were not reported.
The authors reported the number of participants experiencing at
least one episode of pneumonia (93 people in the experimental
group and 203 people in the control group). Using this informa-
tion, we were able to calculate the RR for the cumulative incidence
using the number of participants at risk at the start of the follow-
up period (RR 0.87, 95% CI 0.69 to 1.09; 2513 participants).
However, it is unlikely that all participants will have been observed
for the entire period of follow-up due to loss to follow-up and
competing risk of death (some participants may have died prior
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to the end of follow-up making it impossible to know whether
they would have developed pneumonia if they had not died early
because of another risk).
Similarly, the cumulative incidence of a first pneumonia was re-
ported in Juthani-Mehta 2015 ( 119 first episodes in 434 partic-
ipants randomised in the intervention arm and 94 first episodes
in 400 participants in the control arm). However, as the trial was
stopped for futility, there was wide variation in the duration of
follow-up for the participants and so the use of the number of
randomised participants as a denominator may not be appropri-
ate. Furthermore, the time period to which the incidence pro-
portion relates is unclear. One study followed participants for 24
months and reported fewer participants with pneumonia in the
professional oral care group ( 21 from 184) than the usual oral
care group ( 34 from 182) ( low-quality evidence; RR 0.61, 95%
CI 0.37 to 1.01; 366 participants) ( Yoneyama 2002). The use of
the number of randomised participants as a denominator may not
be appropriate.
Overall, no evidence of an effect was observed for the incidence
proportion of NHAP, with data suggesting either an increase or
decrease in the outcome is possible as a result of professional oral
care.
Mortality (pneumonia-associated)
Three studies reported on pneumonia-associated death (Adachi
2002; Bourigault 2011; Yoneyama 2002). There was no clear ev-
idence of a difference between the groups who received profes-
sional oral care or usual oral care at 18-month follow-up (RR 1.09,
95% CI 0.58 to 2.05; one study, 2513 participants; Analysis 1.3).
At 24-month follow-up, there was evidence that professional oral
care may reduce pneumonia-associated mortality more than usual
oral care (RR 0.41, 95% CI 0.24 to 0.72; two studies, 507 partic-
ipants; Analysis 1.3; low-quality evidence).
Mortality (all-cause)
Two studies reported on all-causemortality (Adachi 2002; Juthani-
Mehta 2015). Very low-quality evidence indicated there was no
clear difference in all-cause mortality between the groups who
received professional oral care or usual oral care (RR 0.55, 95%
CI 0.27 to 1.15; one study, 141 participants; Analysis 1.4). We
considered it inappropriate to pool the data from Juthani-Mehta
2015, but the authors reported an HR of 1.16, 95% CI 0.88 to
1.53 at the time that the study was stopped.
Change in systemic antibiotic use
None of the studies measured this outcome.
Adverse reactions to the interventions
Juthani-Mehta 2015 stated that “there were no protocol-related
serious adverse events, and there were 64 protocol-related non-se-
rious adverse events, all of which were anticipated. The most com-
mon protocol-related non-serious adverse events were oral cavity
disturbances and dental staining”. The oral cavity disturbances
included anything that could have been related to the oral care
intervention, e.g. gum bleeding or mouth sores.
Incidence or prevalence of fever
No study reported fever by time-to-event data. Two studies re-
ported the prevalence of fever (Adachi 2002; Yoneyama 2002).
Adachi 2002 stated that “the occurrence of fevers of 37.8°C or
more in the POHC group was found to be significantly lower
than that in the non-POHC group (P < 0.05)”. They provided
figures only, with no supporting data. Yoneyama 2002 reported
the number of participants who had more than seven consecutive
febrile days during the two-year period of follow-up. One study
suggested that the risk of participants having fever was 51% lower
in the professional oral care group (RR 0.49, 95%CI 0.33 to 0.75;
366 participants; Analysis 1.5).
Change in data on economics and quality of life
None of the studies measured the economics of oral care.
Only one study measured change in quality of life measures (
Yoneyama 2002). The authors evaluated cognitive impairment
with the Mini-Mental State Examination (MMSE), and activities
of daily living (ADLs) with the modified Barthel Index. MMSE
scores tend to reduce with age, but at the end of the 24-month
follow-up, they noted that professional oral care mitigated this
reduction in comparison tousual oral care (intervention group: 1.5
+ 4.9, 170 participants; control group: 3.0 + 5.9, 152 participants;
P = 0.032).
Oral health indices
Yoneyama 2002 reported a change in debris index. They found
a debris index of 2.6 + 0.8 in the professional care group (109
participants), and of 2.5 + 0.8 in the usual care group (90 par-
ticipants). Yoneyama 2002 dichotomised this outcome (improved
or deteriorated) and concluded that professional oral care signifi-
cantly reduced the debris index compared to usual care (RR 2.81,
95% CI 1.39 to 5.69, P = 0.004).
Oral care versus no oral care
No studies evaluated this comparison (see Summary of findings
2).
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Oral care versus no oral care
Population: elderly people
Setting: nursing homes
Intervention: oral care
Comparison: no oral care
Outcomes Illustrative comparative
risks (95% CI)
Relative effect
(95% CI)
Number of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Incidence rate of NHAP No studies
Incidence proportion of
NHAP
No studies
Mortality (pneumonia-as-
sociated)
No studies
Mortality (all- cause) No studies
Adverse effects of inter-
ventions
No studies
NHAP: nursing home-acquired pneumonia
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D I S C U S S I O N
Summary of main results
The aim of this review was to assess the effects of oral care mea-
sures for preventing nursing-home acquired pneumonia (NHAP)
in residents of nursing homes. We identified four eligible RCTs
for the review. The studies focused on the comparison between
professional oral care and usual oral care.
• It was not possible to establish the effects of professional
oral care on the incidence rate of NHAP compared with usual
oral care over an 18-month period (low-quality evidence).
• It was not possible to establish whether or not professional
oral care can lower the number of first episodes of pneumonia
compared with usual care over a 24-month period (low-quality
evidence).
• Professional oral care may reduce pneumonia-associated
death by 60% in comparison with usual oral care at 24-month
follow-up (low-quality evidence).
• We could not draw any conclusions about the effect of
professional oral care compared to usual care on all-cause
mortality (very-low quality evidence).
• Adverse effects were measured in only one study, which was
stopped early. This study identified no serious events.
We did not identify any studies that compared oral care to no oral
care.
Due to the limited quantity of included studies and low quality
of the evidence, we should treat the results cautiously.
Overall completeness and applicability of
evidence
Studies included in the review recruited participants residing in
nursing homes. Some participants were dentate; some were eden-
tulous. Some participants were able to care for themselves; others
were not, possibly suffering from a variety of diseases. We con-
sidered that the results might be applicable to residents with dif-
ferent health conditions in nursing homes; however, no relevant
data about the prevalence of systemic diseases were provided in
the included studies. Two of studies included in the review were
conducted in Japan (Adachi 2002; Yoneyama 2002), one in the
USA (Juthani-Mehta 2015), and one in France (Bourigault 2011).
The review grouped oral care measures into professional oral care
and usual oral care, but oral care protocols varied in both groups
across studies.
It was not possible to blind participants and caregivers to the oral
care measures, which might have led to a Hawthorne effect, and
influenced the results (Sedgwick 2015).
All of our primary outcomes and most of our secondary outcomes
were assessed in the review. Caregivers in nursing homes should
understand that we only assessed the effect of oral care measures
on new incidences of NHAP. Thus, the review does not provide
evidence of whether oral care measures would affect the incidence
or frequency of recurrent pneumonia. We noted that systemic
diseases might be confounding factors that could influence the
death of participants. Only Adachi 2002 reported all causes of
death, and no studies made an attempt to analyse potential effects
of these confounding factors. The studies also investigated the
relationship between oral care measures and the administration of
antibiotics. We were unable to acquire information about whether
oral care measures could reduce expenses in nursing homes.
In conclusion, evidence provided by this review might be applica-
ble for a variety of residents in nursing homes, but it is essential
to adequately consider the limitation and bias of studies included
in the review, and to interpret the data with care.
Quality of the evidence
We assess all the included studies at high risk of bias due to the lack
of blinding of participants; one study was also at high risk of bias
owing to incomplete outcome data (Figure 2). Due to the high
risk of bias in the studies, the quality of evidence was downgraded
one level for incidence rate and cumulative incidence of NHAP,
and two levels for mortality (pneumonia-associated and all-cause).
In most analyses, there was only one study that measured the
outcome or the subgroup. One subgroup consisted of two studies
with no heterogeneity (Analysis 1.3; 24-month follow-up; two
studies; I² = 0%). Hence none of the evidence was downgraded
for inconsistency.
The number of events was mostly insufficient, reflected in the
wide confidence intervals. So the evidence was downgraded for
imprecision for incidence rate, cumulative incidence, and all cause
mortality.
None of the evidence was downgraded for indirectness.
Due to the limitednumber of included studies, we did not generate
a funnel plot to examine the publication bias across studies, thus
none of the evidence was downgraded for this.
Therefore, we downgraded the quality of evidence to low on inci-
dence rate, cumulative incidence of NHAP, and pneumonia-asso-
ciated mortality, and to very low on all-cause mortality (Summary
of findings for the main comparison). We emphasise that it is nec-
essary to treat the evidence with caution, due to the small number
of included studies.
Potential biases in the review process
In order to reduce the risk of publication bias in our review,we con-
ducted a broad search for both published and unpublished studies,
with no restrictions on language. We searched the reference lists
of included studies, and contacted many of the trial authors in or-
der to obtain information that was not included in the published
reports. We also searched the reference lists of other published
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reviews concerning oral care for nursing home residents. How-
ever, we still failed to acquire the data from a potentially relevant
study, entitled ’Chlorhexidine & Pneumonia in Nursing Home
Residents’, registered in clinicaltrials.gov (NCT00841074). We
did not include Ohsawa 2003 because we were unable to clarify
whether the data were part of the study described in Yoneyama
2002.
For this review, we also chose very broad inclusion criteria, which
resulted in a clinically heterogeneous group of studies including
elderly people who were either dentulous or edentulous, with or
without cognitive impairment, and possibly with a variety of sys-
temic diseases. The trial method was described poorly in some
studies, which made it difficult to assess the similarity between
studies. Theremight have been potential variation in the diagnoses
and assessment of outcomes. Another potential bias in this review
was that there is no gold standard used to diagnose NHAP.
In data analysis, we assessedwhether the follow-up duration of oral
care measures influenced the results in a subgroup analysis. We
noticed that oral care measures were provided by different care-
givers, or participants themselves. Discrepancy in the performance
of operators might influence results, but due to the limited studies
and incomplete information, we did not attempt further analysis.
The results from Juthani-Mehta 2015 were in contradiction to
the results of the other included studies. We excluded it from
meta-analysis due to the variable duration of follow-up among
participants. Hence, we did not downgrade the relevant evidence
due to inconsistency.Moreover, there are conflicting opinions as to
whether trials stopped early should be included in a meta-analysis.
Agreements and disagreements with other
studies or reviews
Other reviews of the effects of oral care measures on NHAP have
been published (El-Rabbany 2015; Kaneoka 2015; Sjögren 2016).
These three systematic reviews included participants in hospitals as
well as nursing homes. El-Rabbany 2015 concluded that chlorhex-
idine might be an effective means of lowering the risk for hospital-
acquired and ventilator-associated pneumonia, but the efficacy of
other prophylactic oral care measures, such as tooth brushing or
iodine swab, was uncertain. Kaneoka 2015 suggested a preventive
effect of oral care measures on healthcare-associated pneumonia in
participantswithoutmechanical ventilation. Sjgren 2016 reported
that oral care provided by dental personnel may reduce mortality
fromhealthcare-associated pneumonia, whereas oral care provided
by nursing personnel probably resulted in little or no difference
from usual care. This Cochrane review found that professional
oral care may reduce mortality due to pneumonia when compared
to usual care at 24 months; however, our confidence in this effect
estimate was limited. In terms of the incidence rate or proportion
of NHAP, the limited body of evidence indicated that professional
oral care may have little or no difference in these outcomes at 24
months. However, our confidence in these effects is limited.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Low-quality evidence suggested that professional oral care may
reduce mortality due to pneumonia compared to usual care, when
measured at 24 months. Low-quality evidence was inconclusive
about the effects of professional care compared to usual oral care
on incidence of nursing-home acquired pneumonia, number of
first episodes of nursing-home acquired pneumonia, andmortality
from any cause. The only study tomeasure adverse effects reported
that there were no serious adverse effects. We found no high-
quality evidence to determine which oral care measures are most
effective for reducing nursing home-acquired pneumonia. Further
trials are needed to draw reliable conclusions.
Implications for research
Considering the limited number of trials in this field, there is a
need for more trials focusing on the effect of oral care measures
on nursing home-acquired pneumonia (NHAP) prevention. We
hope future studies can address the following issues.
• Participants: studies with a large number of participants in
nursing homes are expected. Sample size calculation and baseline
comparability should be taken into consideration.
• Intervention: more oral care measures are needed in future
RCTs, for instance, electronic toothbrush, dental floss,
interdental brush, and different mouthrinses. More practical and
flexible oral care protocols aimed at residents with different
conditions could be used; for example, how can we ensure
elderly people with dementia can accept the same oral care
measures as mentally healthy residents? Measures for preventing
aspiration should be considered as well.
• Comparisons: so far, all trials in this field focused on the
comparison between professional oral care and usual oral care;
future trials should consider comparisons of different oral care
measures.
• Outcomes: we recommend that incidence with fixed
follow-up duration, as time-to-event data, be measured. We also
recommend that trials measure first and recurrent pneumonia.
We suggest future studies include or analyse the participants
based on stratification of NHAP risk factors, such as chronic
obstructive pulmonary diseases, cardiovascular diseases, diabetes,
and age. In addition, we hope future studies will pay more
attention to systemic antibiotic use, economics, quality of life,
and oral health indices.
• Risk of bias: future studies should find ways to reduce the
risk of bias. Although blinding of participants and personnel may
not be easy, blinding of outcome assessment should be achieved.
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• Method of analyses: if there is uncertainty as to whether all
participants can reasonably be followed for the entire follow-up
period, then a time-to-event approach would be the most
appropriate method of analysis. Analysing cumulative incidence
as though all participants are observed for the entire follow-up
period can lead to erroneous inferences.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Adachi 2002
Methods Study design: RCT, 2 parallel groups
Location: Tokyo, Japan
Number of centres: 2
Study period: not stated
Funding source: Grant from Tokyo Dental College to the Oral Health Science Center
Participants Setting: nursing homes
Inclusion criteria: elderly in nursing homes, afflicted with a variety of medical problems,
and under medication of some kind
Exclusion criteria: not stated
Number randomised: 141 (female/male: 104/37, mean age: 84; intervention group:
77; control group: 64); however, only 88 participants assigned at the beginning of the
study had outcomes correlated to pneumonia
Number evaluated: 88 (intervention group: 40; control group: 48)
Interventions Comparison: caregiver-provided professional oral care versus caregiver-provided
usual oral care
Intervention group: brushing teeth, buccal mucosa and tongue (electric brush with an
automatic water supply, an interdental brush, a sponge brush) + cleaning denture, by
dental hygienists
Control group: swabbing teeth, buccalmucosa, tongue (sponge brush) + cleaning denture
Operators: dental hygienists, number not stated
As for daily oral care, those who were independent enough used the washing facilities in
their rooms to rinse out their mouths after each meal, but the other participants were
assisted to carry out oral cleansing once a day by the nursing home staff
Outcomes 1. Mortality (pneumonia-associated; 24 months of follow-up)
2. Mortality (all-cause; 24 months of follow-up)
3. Prevalence of fever (24 months of follow-up)
Notes Sample size calculation: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The experimental group consisted
of 77 subjects who received POHC, and
the control group of 64 subjects who did
not receive POHC treatment; the subjects
were divided randomly.”
Comment: unclear risk; method of se-
quence generation not described
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Adachi 2002 (Continued)
Allocation concealment (selection bias) Unclear risk Quote: “The experimental group consisted
of 77 subjects who received POHC, and
the control group of 64 subjects who did
not receive POHC treatment; the subjects
were divided randomly.”
Comment: unclear risk; method of alloca-
tion concealment not described
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: high risk; blinding not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Comment: unclear risk; unclear informa-
tion about blinding of outcome assessors
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: high risk; no withdrawals, but
authors did not report the pneumonia-re-
lated data from all included participants
(88 in 141 participants had pneumonia-re-
lated outcome)
Selective reporting (reporting bias) Low risk Comment: low risk; expected outcomes re-
ported, including fatal causes, except pneu-
monia
Other bias Low risk Comment: low risk; no other sources of
bias identified
Bourigault 2011
Methods Study design: cluster-RCT, 2 parallel groups
Location: France
Number of centres: 18
Study period: from June 2005 to December 2006
Funding source:Colgate-Palmolive and the ’ProgrammeHospitalier de RechercheClin-
ique’ 2003
Participants Setting: nursing homes
Inclusion criteria: volunteer facilities with more than 30 beds and patients aged > 65
years
Exclusion criteria: not stated
Number randomised: not stated
Number evaluated: 2513 participants (Intervention group: 868; control group: 1645)
Interventions Comparison: professional oral care versus usual oral care
Intervention group: brushing teeth, buccal mucosa and tongue (three times a day and
after each meal) + mouthrinse (chlorhexidine) + dental visit (annual visit to dentists)
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Bourigault 2011 (Continued)
Control group: usual mouth care (not stated in detail)
Operators: not stated
Outcomes 1. Incidence of first NHAP (18 months of follow-up)
2. Mortality (pneumonia-associated; 18 months of follow-up)
Notes Sample size calculation: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The 18 facilities were allocated at
random, nine to the experimental group
and nine to the control group.”
Comment: unclear risk; method of se-
quence generation not described
Allocation concealment (selection bias) Unclear risk Quote: “The 18 facilities were allocated at
random, nine to the experimental group
and nine to the control group.”
Comment: unclear risk; method of alloca-
tion concealment not described
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: high risk; blinding not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Comment: unclear risk; unclear informa-
tion about blinding of outcome assessors
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Quote: “In the end, the analysis covered
nine facilities in the experimental group
(868 participants) and eight facilities in the
control group (1645 participants).”
Comment: unclear risk; patients of a facil-
ity in control group were not included in
analysis, but the number was not stated
Selective reporting (reporting bias) Low risk Comment: low risk; expected outcomes re-
ported
Other bias Low risk Comment: low risk; no other sources of
bias identified
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Juthani-Mehta 2015
Methods Study design: cluster-RCT, 2 parallel groups
Location: New Haven, Connecticut, USA
Number of centres: 36
Study period: not stated
Funding source: The National Institutes of Health, the National Institute on Aging
(NIA) (K23AG028691, R01AG030575, K07AG030093, and P30AG021342)
Participants Setting: nursing homes
Inclusion criteria: nursing home facilities housing at least 90 residents. Long-term care
residents age > 65 years, resident at the nursing home for at least 1 month, with at least
1 of 2 modifiable risk factors for pneumonia (i.e. impaired oral hygiene, swallowing
difficulty)
Exclusion criteria: (1) housing for short-term rehabilitation; (2) presence of a gastric
(including percutaneous endoscopic gastrostomy or nasogastric tube) or jejunostomy
tube; (3) presence of a tracheostomy; (4) life expectancy < 3 months; (5) current use
of chlorhexidine; (6) pneumonia within the previous 6 weeks; (7) previous enrolment
in the study; (8) unwillingness to give informed consent (from residents or designated
surrogates); (9) non-English speaking; or (10) inappropriateness for the study in the
opinion of nursing home administration
Number randomised: 834 participants (female/male: 636/198, mean age: 86.3; inter-
vention group: 434; control group: 400)
Number evaluated: 834 participants (259 participants lost to follow-up, but intention-
to-treat analysis was used)
Interventions Comparison: caregivers provided or instructed professional oral care + upright
feeding positioning versus usual oral care + usual feeding position
Intervention group: brushing teeth (twice a day) + cleaning denture + mouthrinse (0.
12% chlorhexidine oral rinse, twice a day) + upright feeding positioning, by nurses. (The
intervention protocol was tailored to participants who could either perform self-care or
required assistance.)
Control group: usual oral care + usual feeding position (not stated in detail)
Operators: nursing home staff, number not stated
Outcomes 1. Incidence of first NHAP (up to 30 months of follow-up)
2. Mortality (all-cause; up to 30 months of follow-up)
3. Adverse reactions to the interventions (up to 30 months of follow-up)
Notes Sample size calculation: stated in detail. The target sample size was 828 participants to
detect a 25% reduction in the cumulative 2.5-year first pneumonia rate with intervention
relative to control assuming a type I error of 0.05 (2-sided), 80% power, an annual loss
to follow-up rate of 20% (death, transfer out of the nursing home), equal allocation and
an intracluster correlation (ICC) of 0.005 from a previous study
Risk of bias
Bias Authors’ judgement Support for judgement
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Juthani-Mehta 2015 (Continued)
Random sequence generation (selection
bias)
Low risk Quote: “Homes were randomized within
each stratumusing, a permuted block de-
sign with equal allocation to intervention
or control arms.”
Comment: low risk
Allocation concealment (selection bias) Low risk Quote: “After enrolment, the randomiza-
tion status of the home was revealed.”
Comment: low risk
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: high risk; blinding not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “Blinded study personnel per-
formed screening assessments and ap-
proached eligible residents (or designated
surrogates) for consent.”
Comment: low risk
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Analyses of primary and secondary
endpoints were by intent-to-treat.”
Comment: low risk
Selective reporting (reporting bias) Low risk Comment: low risk; expected outcomes re-
ported
Other bias Low risk Comment: low risk; no other sources of
bias identified.
Yoneyama 2002
Methods Study design: RCT, 2 parallel groups
Location: Japan
Number of centres: 11
Study period: not stated
Funding source: Comprehensive Research on Aging and Health from 1999 to 2000 of
the Japan Welfare Ministry
Participants Setting: nursing homes in Japan
Inclusion criteria: physical symptoms and cognitive impairment must have been sta-
ble for the preceding 3 months. During this 3-month period, no participant had acute
disorders (e.g. severe infection, heart failure, or stroke requiring special treatment and
intensive care). Chronic diseases suffered by participants included previous stroke, hy-
pertension, arrhythmia, previous myocardial infection, diabetes mellitus, and inactive
gastric ulcer. Mental function varied from slight cognitive impairment to dementia
Exclusion criteria: no participant had any chronic pulmonary disease, such as chronic
obstructive pulmonary disease, bronchial asthma, or pulmonary fibrosis. No participant
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Yoneyama 2002 (Continued)
had feeding tubes
Number randomised: 417 participants
Number evaluated: 366 participants (female/male: 293/73, mean age: 82.0; interven-
tion group: 184; control group: 182); 51 participants were excluded from the analysis
because they died from causes other than pneumonia during follow-up
Interventions Comparison: caregiver-provided professional oral care versus usual oral care
Intervention group (N = 184): brushing teeth, mucosa and tongue (approximately 5
minutes after each meal without dentifrice) + swabbing mucosa (with 1% povidone
iodine, used in some cases), by nurses or caregivers, + dental visit (plaque and calculus
control once a week) by dentists or dental hygienists, + cleaning denture (every day)
Control group (N = 182): brushing teeth (once a day or irregularly) by themselves
without caregivers + cleaning denture (every day)
Operators: nurses, caregivers, dentists, and dental hygienists. Number not stated
Outcomes 1. Incidence of first NHAP (24 months of follow-up)
2. Mortality (pneumonia-associated; 24 months of follow-up)
3. Prevalence of fever (24 months of follow-up)
4. Change in data on quality of life (24 months of follow-up)
5. Oral health indices (24 months of follow-up)
Notes Sample size calculation: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The patients were randomly se-
lected from the same floor and nursing
team in each nursing home. Randomiza-
tion was made from a random-numbers ta-
ble, and the list was held independently of
the investigators.”
Comment: low risk
Allocation concealment (selection bias) Unclear risk Comment: unclear risk; method of alloca-
tion concealment not described
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: high risk; blinding not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “Two radiologists who were not in-
volved in the studies made the diagnosis of
pneumonia.”
Comment: low risk
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Yoneyama 2002 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Quote: “51 patients were excluded from
the analysis because they died from causes
other than pneumonia during follow-up.”
Comment: unclear risk; the ratio of partic-
ipants excluded from the analysis was 12.
2%
Selective reporting (reporting bias) Low risk Comment: low risk; expected outcomes re-
ported
Other bias Low risk Comment: low risk; no other sources of
bias identified
POHC = professional oral hygiene care; NHAP = nursing home-acquired pneumonia; RCT = randomised controlled trial
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bassim 2008 Retrospective cohort study
Hollaar 2017 Non-RCT
Izumi 2016 Not conducted to assess pneumonia incidence or mortality
Morino 2010 Quasi-randomised trial
Quagliarello 2009 Not conducted to assess pneumonia incidence or mortality
Watando 2004 Not conducted to assess pneumonia incidence or mortality
Characteristics of studies awaiting assessment [ordered by study ID]
NCT00841074
Methods Study design: RCT, 2 parallel groups
Location: USA
Number of centres: not stated
Study period: not stated
Funding source: not stated
32Oral care measures for preventing nursing home-acquired pneumonia (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
NCT00841074 (Continued)
Participants Setting: nursing homes
Inclusion criteria: participants must be at least 65 years old; be dependent in 2 or more activities of daily living
(ADL), one of which must be personal hygiene, wear complete or partial dentures, or a combination; expected to be
a resident in a nursing home for two years
Exclusion criteria: existing pneumonia; history of chlorhexidine reaction or allergy,multiple medication or substance
allergies; receiving chlorhexidine oral application at enrolment as prescribed by physician or dentist
Number randomised: 75 participants
Number evaluated: unclear
Interventions Comparison: Peridex mouthwash versus placebo mouthwash
Intervention group: 0.12% chlorhexidine mouthwash spray, ~1.3 mL, twice a day
Control group: placebo mouthwash spray application of ~1.3 mL twice a day
Outcomes 1. Incidence of NHAP (12 months of follow-up)
2. Oral health indices (12 months of follow-up)
Notes It was stated that the trial was completed, but no published articles retrieved and no useful data available. We tried
to contact the authors for the data we needed. The author replied that “The study is finished but we did not obtain
any significant results and they have not been published”, but when we asked for further information, we received
no further reply. The study will be considered for inclusion once the trial authors provide the outcome data
Ohsawa 2003
Methods Study design: RCT, 2 parallel groups
Location: Japan
Number of centres: 11
Study period: not stated
Funding source: not stated
Participants Setting: nursing homes in Japan
Inclusion criteria: physical symptoms and cognitive impairment must have been stable for the preceding 3 months.
During this 3-month period, potential participants must not have had acute disorders (e.g. severe infection, heart
failure, or stroke requiring special treatment and intensive care). Chronic diseases suffered by participants included
previous stroke, hypertension, arrhythmia, previous myocardial infection, diabetes mellitus, and inactive gastric ulcer.
Mental function varied from slight cognitive impairment to dementia
Exclusion criteria: no chronic pulmonary disease such as chronic obstructive pulmonary disease, bronchial asthma,
or pulmonary fibrosis. No feeding tubes
Number randomised: 49 participants (female/male: 41/8, mean age: 85.5 ± 8.0)
Number evaluated: 49 participants (female/male: 41/8, mean age: 85.5 ± 8.0)
Interventions Comparison: caregivers provided professional oral care versus usual oral care
Intervention group (n = 25): brushing teeth (after each meal) + swabbing mucosa (with 1% povidone iodine, used
in some cases), by nurses or caregivers + dental visit (twice or three times a week), by dentists or dental hygienists +
cleaning denture (every day)
Control group (n = 24): brushing teeth (after each meal), by caregivers + cleaning denture (every day)
Operators: nurses, caregivers, dentists and dental hygienists. Number not stated
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Ohsawa 2003 (Continued)
Outcomes 1. Incidence of first NHAP (24 months of follow-up)
2. Prevalence of fever (24 months of follow-up)
3. Change in data on quality of life (24 months of follow-up)
Notes Sample size calculation: not reported
We were not sure whether the data partially overlapped with that of Yoneyama 2002.We tried to contact trial authors,
but did not receive a reply
NHAP = nursing home-acquired pneumonia
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D A T A A N D A N A L Y S E S
Comparison 1. Professional oral care versus usual oral care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Incidence rate of NHAP 1 Hazard Ratio (Random, 95% CI) Totals not selected
1.1 18-month follow-up 1 Hazard Ratio (Random, 95% CI) 0.0 [0.0, 0.0]
2 Incidence proportion
(cumulative incidence) of
NHAP
2 Risk Ratio (M-H, Random, 95% CI) Totals not selected
2.1 18-month follow-up 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2.2 24-month follow-up 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
3 Mortality
(pneumonia-associated)
3 3020 Risk Ratio (M-H, Random, 95% CI) 0.56 [0.25, 1.27]
3.1 18-month follow-up 1 2513 Risk Ratio (M-H, Random, 95% CI) 1.09 [0.58, 2.05]
3.2 24-month follow-up 2 507 Risk Ratio (M-H, Random, 95% CI) 0.41 [0.24, 0.72]
4 Mortality (all-cause) 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4.1 24-month follow-up 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Prevalance of fever 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5.1 24-month follow-up 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Analysis 1.1. Comparison 1 Professional oral care versus usual oral care, Outcome 1 Incidence rate of
NHAP.
Review: Oral care measures for preventing nursing home-acquired pneumonia
Comparison: 1 Professional oral care versus usual oral care
Outcome: 1 Incidence rate of NHAP
Study or subgroup log [Hazard Ratio] Hazard Ratio Hazard Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
1 18-month follow-up
Bourigault 2011 -0.4308 (0.4118) 0.65 [ 0.29, 1.46 ]
0.2 0.5 1 2 5
Favours professional care Favours usual care
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Analysis 1.2. Comparison 1 Professional oral care versus usual oral care, Outcome 2 Incidence proportion
(cumulative incidence) of NHAP.
Review: Oral care measures for preventing nursing home-acquired pneumonia
Comparison: 1 Professional oral care versus usual oral care
Outcome: 2 Incidence proportion (cumulative incidence) of NHAP
Study or subgroup professional care usual care Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 18-month follow-up
Bourigault 2011 93/868 203/1645 0.87 [ 0.69, 1.09 ]
2 24-month follow-up
Yoneyama 2002 21/184 34/182 0.61 [ 0.37, 1.01 ]
0.2 0.5 1 2 5
Favours professional care Favours usual care
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Analysis 1.3. Comparison 1 Professional oral care versus usual oral care, Outcome 3 Mortality (pneumonia-
associated).
Review: Oral care measures for preventing nursing home-acquired pneumonia
Comparison: 1 Professional oral care versus usual oral care
Outcome: 3 Mortality (pneumonia-associated)
Study or subgroup professional care usual care Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 18-month follow-up
Bourigault 2011 15/868 26/1645 40.2 % 1.09 [ 0.58, 2.05 ]
Subtotal (95% CI) 868 1645 40.2 % 1.09 [ 0.58, 2.05 ]
Total events: 15 (professional care), 26 (usual care)
Heterogeneity: not applicable
Test for overall effect: Z = 0.28 (P = 0.78)
2 24-month follow-up
Adachi 2002 2/77 8/64 18.7 % 0.21 [ 0.05, 0.94 ]
Yoneyama 2002 14/184 30/182 41.1 % 0.46 [ 0.25, 0.84 ]
Subtotal (95% CI) 261 246 59.8 % 0.41 [ 0.24, 0.72 ]
Total events: 16 (professional care), 38 (usual care)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.93, df = 1 (P = 0.33); I2 =0.0%
Test for overall effect: Z = 3.10 (P = 0.0020)
Total (95% CI) 1129 1891 100.0 % 0.56 [ 0.25, 1.27 ]
Total events: 31 (professional care), 64 (usual care)
Heterogeneity: Tau2 = 0.32; Chi2 = 6.04, df = 2 (P = 0.05); I2 =67%
Test for overall effect: Z = 1.39 (P = 0.17)
Test for subgroup differences: Chi2 = 5.11, df = 1 (P = 0.02), I2 =80%
0.05 0.2 1 5 20
Favours professional care Favours usual care
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Analysis 1.4. Comparison 1 Professional oral care versus usual oral care, Outcome 4 Mortality (all-cause).
Review: Oral care measures for preventing nursing home-acquired pneumonia
Comparison: 1 Professional oral care versus usual oral care
Outcome: 4 Mortality (all-cause)
Study or subgroup professional care usual care Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 24-month follow-up
Adachi 2002 10/77 15/64 0.55 [ 0.27, 1.15 ]
0.2 0.5 1 2 5
Favours professional care Favours usual care
Analysis 1.5. Comparison 1 Professional oral care versus usual oral care, Outcome 5 Prevalance of fever.
Review: Oral care measures for preventing nursing home-acquired pneumonia
Comparison: 1 Professional oral care versus usual oral care
Outcome: 5 Prevalance of fever
Study or subgroup professional care usual care Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 24-month follow-up
Yoneyama 2002 27/184 54/182 0.49 [ 0.33, 0.75 ]
0.5 0.7 1 1.5 2
Favours professional care Favours usual care
38Oral care measures for preventing nursing home-acquired pneumonia (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A P P E N D I C E S
Appendix 1. Cochrane Oral Health Trials Register search strategy
1 (((oral or mouth or dental) and (care or hygiene or health)):ti,ab) AND (INREGISTER)
2 ((care and teeth):ti,ab) AND (INREGISTER)
3 ((denture* and (clean* or clens*)):ti,ab) AND (INREGISTER)
4 ((plaque and (control* or remov*)):ti,ab) AND (INREGISTER)
5 ((mouthwash* or mouth-wash* or mouthrins* or mouth-rins* or oral-rins* or toothpaste* or “tooth paste*” or dentifrice* or
toothbrush* or “tooth brush*” or fluorid* or chlorhexidine or betadine* or triclosan or cepacol or Corsodyl or Peridex or Hibident
or Prexidine or Parodex or Chlorexil or Periodont or Eludril or Perioxidin or Chlorohex or Savacol or Periogard or Chlorhexamed or
Nolvasan or Sebidin or Tubulicid or hibitane):ti,ab) AND (INREGISTER)
6 ((antiseptic* or antiiinfect* or “local microbicide*” or “topical microbicide”):ti,ab) AND (INREGISTER)
7 (((oral or mouth or dental) and (foam* or gel*)):ti,ab) AND (INREGISTER)
8 ((floss* or “interdental brush*” or (tooth and clean*) or (teeth and clean*) or (denture* and hygien*) or (tongue* and scrap*)):ti,ab)
AND (INREGISTER)
9 (“professional oral health care”:ti,ab) AND (INREGISTER)
10 (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9) AND (INREGISTER)
11 (pneumonia:ti,ab) AND (INREGISTER)
12 ((“gram negative bacilli” or “psuedomonas aeruginosa” or enterobacter* or pneumonitis or “pulmonary inflammation” or “lung
inflammation”):ti,ab) AND (INREGISTER)
13 (#11 or #12) AND (INREGISTER)
14 (#10 and #13) AND (INREGISTER)
Appendix 2. Cochrane Central Register of Controlled Trials (CENTRAL) search strategy
#1 [mh “preventive dentistry”]
#2 [mh dentifrices]
#3 [mh ˆmouthwashes]
#4 [mh ˆ“oral health”]
#5 [mh ˆ“Anti-infective agents, local”]
#6 [mh ˆCetylpyridinium]
#7 [mh ˆChlorhexidine]
#8 [mh ˆPovidine-iodine]
#9 ((oral or mouth or dental) near/3 (care or hygiene or health)):ti,ab
#10 (care near/3 teeth):ti,ab
#11 (denture* near/5 (clean* or clens*)):ti,ab
#12 (plaque near/3 (control* or remov*)):ti,ab
#13 (mouthwash* or mouth-wash* or mouthrins* or mouth-rins* or oral-rins* or toothpaste* or “tooth paste*” or dentifrice* or
toothbrush* or “tooth brush*” or fluorid* or chlorhexidine or betadine* or triclosan or cepacol or Corsodyl or Peridex or Hibident
or Prexidine or Parodex or Chlorexil or Periodont or Eludril or Perioxidin or Chlorohex or Savacol or Periogard or Chlorhexamed or
Nolvasan or Sebidin or Tubulicid or hibitane):ti,ab
#14 (antiseptic* or antiiinfect* or “local microbicide*” or “topical microbicide”):ti,ab
#15 ((oral or mouth or dental) near/5 (foam* or gel*)):ti,ab
#16 (floss* or “interdental brush*” or (tooth near/5 clean*) or (teeth near/5 clean*) or (denture* near/5 hygien*) or (tongue* near/5
scrap*)):ti,ab
#17 “professional oral health care”:ti,ab
#18 {or #1-#17}
#19 [mh pneumonia]
#20 pneumonia:ti,ab
#21 (“gram negative bacilli” or “psuedomonas aeruginosa” or enterobacter* or pneumonitis or “pulmonary inflammation” or “lung
inflammation”):ti,ab
#22 {or #19-#21}
39Oral care measures for preventing nursing home-acquired pneumonia (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
#23 #18 and #22
Appendix 3. MEDLINE Ovid search strategy
1. exp Preventive dentistry/
2. exp Dentifrices/
3. Mouthwashes/
4. Oral health/
5. Anti-infective agents, local/
6. Cetylpyridinium/
7. Chlorhexidine/
8. Povidone-iodine/
9. ((oral or mouth or dental) adj3 (care or hygiene or health)).ti,ab.
10. (care adj3 teeth).ti,ab.
11. (denture$ adj5 (clean$ or clens$)).ti,ab.
12. (plaque adj3 (control$ or remov$)).ti,ab.
13. (mouthwash$ or mouth-wash$ or mouthrins$ or mouth-rins$ or oral-rins$ or toothpaste$ or “tooth paste$” or dentifrice$ or
toothbrush$ or “tooth brush$” or fluorid$ or chlorhexidine or betadine$ or triclosan or cepacol or Corsodyl or Peridex or Hibident
or Prexidine or Parodex or Chlorexil or Peridont or Eludril or Perioxidin or Chlorohex or Savacol or Periogard or Chlorhexamed or
Nolvasan or Sebidin or Tubulicid or hibitane).ti,ab.
14. (antiseptic$ or antiinfect$ or “local microbicide$” or “topical microbicide$”).ti,ab.
15. ((oral or mouth or dental) adj5 (foam$ or gel$)).ti,ab.
16. (floss$ or “interdental brush$” or (tooth adj5 clean$) or (teeth adj5 clean$) or (denture$ adj5 hygien$) or (tongue$ adj5 scrap$)).ti,ab.
17. “professional oral health care”.ti,ab.
18. or/1-17
19. exp Pneumonia/
20. pneumonia.ti,ab.
21. (“gram negative bacilli” or “pseudomonas aeruginosa” or “pseudomonas aruginosa” or enterobacter$ or pneumonitis or “pulmonary
inflammation” or “lung inflammation”).ti,ab.
22. or/19-21
23. 18 and 22
This subject search was linked to the Cochrane Highly Sensitive Search Strategy (CHSSS) for identifying randomised trials in MED-
LINE: sensitivity-maximising version (2008 revision) as referenced in Chapter 6.4.11.1 and detailed in box 6.4.c of The Cochrane
Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011] (Lefebvre 2011).
1. randomized controlled trial.pt.
2. controlled clinical trial.pt.
3. randomized.ab.
4. placebo.ab.
5. drug therapy.fs.
6. randomly.ab.
7. trial.ab.
8. groups.ab.
9. or/1-8
10. exp animals/ not humans.sh.
11. 9 not 10
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Appendix 4. Embase Ovid search strategy
1. exp Preventive dentistry/
2. Toothpaste/
3. Mouthwash/
4. Mouth hygiene/
5. Anti-infective agent/
6. Cetylpyridinium salt/
7. Chlorhexidine/
8. Povidone iodine/
9. ((oral or mouth or dental) adj3 (care or hygiene or health)).ti,ab.
10. (care adj3 teeth).ti,ab.
11. (denture$ adj5 (clean$ or clens$)).ti,ab.
12. (plaque adj3 (control$ or remov$)).ti,ab.
13. (mouthwash$ or mouth-wash$ or mouthrins$ or mouth-rins$ or oral-rins$ or toothpaste$ or “tooth paste$” or dentifrice$ or
toothbrush$ or “tooth brush$” or fluorid$ or chlorhexidine or betadine$ or triclosan or cepacol or Corsodyl or Peridex or Hibident
or Prexidine or Parodex or Chlorexil or Peridont or Eludril or Perioxidin or Chlorohex or Savacol or Periogard or Chlorhexamed or
Nolvasan or Sebidin or Tubulicid or hibitane).ti,ab.
14. (antiseptic$ or antiinfect$ or “local microbicide$” or “topical microbicide$”).ti,ab.
15. ((oral or mouth or dental) adj5 (foam$ or gel$)).ti,ab.
16. (floss$ or “interdental brush$” or (tooth adj5 clean$) or (teeth adj5 clean$) or (denture$ adj5 hygien$) or (tongue$ adj5 scrap$)).ti,ab.
17. “professional oral health care”.ti,ab.
18. or/1-17
19. exp Pneumonia/
20. pneumonia.ti,ab.
21. (“gram negative bacilli” or “pseudomonas aeruginosa” or “pseudomonas aruginosa” or enterobacter$ or pneumonitis or “pulmonary
inflammation” or “lung inflammation”).ti,ab.
22. or/19-21
23. 18 and 22
This subject search was linked to an adapted version of the Cochrane Centralised Search Project filter for identifying RCTs in Embase
Ovid (see http://www.cochranelibrary.com/help/central-creation-details.html for information):
1. Randomized controlled trial/
2. Controlled clinical study/
3. Random$.ti,ab.
4. randomization/
5. intermethod comparison/
6. placebo.ti,ab.
7. (compare or compared or comparison).ti.
8. ((evaluated or evaluate or evaluating or assessed or assess) and (compare or compared or comparing or comparison)).ab.
9. (open adj label).ti,ab.
10. ((double or single or doubly or singly) adj (blind or blinded or blindly)).ti,ab.
11. double blind procedure/
12. parallel group$1.ti,ab.
13. (crossover or cross over).ti,ab.
14. ((assign$ or match or matched or allocation) adj5 (alternate or group$1 or intervention$1 or patient$1 or subject$1 or partici-
pant$1)).ti,ab.
15. (assigned or allocated).ti,ab.
16. (controlled adj7 (study or design or trial)).ti,ab.
17. (volunteer or volunteers).ti,ab.
18. trial.ti.
19. or/1-18
20. (exp animal/ or animal.hw. or nonhuman/) not (exp human/ or human cell/ or (human or humans).ti.)
21. 19 not 20
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Appendix 5. CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature) search
strategy
S22 S17 and S21
S21 S18 or S19 or S20
S20 (“gram negative bacilli” or “psuedomonas aeruginosa” or enterobacter* or pneumonitis or “pulmonary inflammation” or “lung
inflammation”)
S19 pneumonia
S18 (mh pneumonia+)
S17 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16
S16 “professional oral health care”
S15 (floss* or “interdental brush*” or (tooth N5 clean*) or (teeth N5 clean*) or (denture* N5 hygien*) or (tongue* N5 scrap*))
S14 ((oral or mouth or dental) N5 (foam* or gel*))
S13 (antiseptic* or antiiinfect* or “local microbicide*” or “topical microbicide”)
S12 (mouthwash* or mouth-wash* or mouthrins* or mouth-rins* or oral-rins* or toothpaste* or “tooth paste*” or dentifrice* or
toothbrush* or “tooth brush*” or fluorid* or chlorhexidine or betadine* or triclosan or cepacol or Corsodyl or Peridex or Hibident
or Prexidine or Parodex or Chlorexil or Periodont or Eludril or Perioxidin or Chlorohex or Savacol or Periogard or Chlorhexamed or
Nolvasan or Sebidin or Tubulicid or hibitane)
S11 (plaque N3 (control* or remov*))
S10 (denture* N5 (clean* or clens*))
S9 (care N3 teeth)
S8 ((oral or mouth or dental) N3 (care or hygiene or health))
S7 (MH “Povidone-Iodine”)
S6 (MH “Chlorhexidine”)
S5 (mh “Anti-infective agents, local”)
S4 (mh “oral health”)
S3 (mh mouthwashes)
S2 (mh dentifrices)
S1 (mh “preventive dentistry+”)
The above subject search was linked to Cochrane Oral Health’s filter for identifying RCTs in CINAHL EBSCO:
S1 MH Random Assignment or MH Single-blind Studies or MHDouble-blind Studies or MH Triple-blind Studies or MH Crossover
design or MH Factorial Design
S2 TI (“multicentre study” or “multicenter study” or “multi-centre study” or “multi-center study”) or AB (“multicentre study” or
“multicenter study” or “multi-centre study” or “multi-center study”) or SU (“multicentre study” or “multicenter study” or “multi-
centre study” or “multi-center study”)
S3 TI random* or AB random*
S4 AB “latin square” or TI “latin square”
S5 TI (crossover or cross-over) or AB (crossover or cross-over) or SU (crossover or cross-over)
S6 MH Placebos
S7 AB (singl* or doubl* or trebl* or tripl*) or TI (singl* or doubl* or trebl* or tripl*)
S8 TI blind* or AB mask* or AB blind* or TI mask*
S9 S7 and S8
S10 TI Placebo* or AB Placebo* or SU Placebo*
S11 MH Clinical Trials
S12 TI (Clinical AND Trial) or AB (Clinical AND Trial) or SU (Clinical AND Trial)
S13 S1 or S2 or S3 or S4 or S5 or S6 or S9 or S10 or S11 or S12
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Appendix 6. Chinese Biomedical Literature Database search strategy
1. : / / - :-
2. : / / - :-
3. : / / - :-
4. : / / - :-
5. : / / - :-
6. #5 or #4 or #3 or #2 or #1 - :-
7. : / / - :-
8. #7 and #6 - :-
Appendix 7. China National Knowledge Infrastructure search strategy
= AND = AND ( = OR = )
Appendix 8. ClinicalTrials.gov search strategy
pneumonia and nursing home
Appendix 9. WHO International Clinical Trials Registry Platform search strategy
pneumonia and nursing home
Appendix 10. Sciencepaper Online search strategy
= OR = OR = AND = , limit to
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